Jul 31, 2015 at 10:06 | Source: CNBC-TV18
But it is also evident, as discussed recently that another reason is the legacy non-performing loan (NPL) issue in the state-owned part of the banking sector & the continuing failure to recapitalise those state-owned banks, Wood said.
Jul 28, 2015 at 13:50 | Source:
According to the brokerage, strong deal momentum on the enterprise side, strategic acquisitions and waning volatility of the legacy business may spell revival.
Jul 27, 2015 at 08:18 | Source: CNBC-TV18
"Our base case would be a 10-12 percent average pay hike. This should be a positive for discretionary consumption plays," Mahesh Nandurkar, CLSA said.
Jul 24, 2015 at 10:41 | Source:
Kotak has downgraded the stock to reduce from add. It has also cut FY2016-17 earnings by 1 percent/4 percent. It states Wipro will struggle to be a core portfolio bet due to a long history of missed strategic opportunities.
Jul 24, 2015 at 08:57 | Source:
The deal will give Lupin access to specialty generic drugs and niche products in dermatology, gastro intestinal and injectables
Jul 23, 2015 at 09:26 | Source: CNBC-TV18
Nandurkar said the brokerage continued to stay cautious in the near-term on earnings downgrade possibilities.
Jul 20, 2015 at 15:55 | Source:
CLSA advised buying the stock with a target price of Rs 1900. Though the brokerage cut CY15-17 estimates by 10-16 percent, it expects better days ahead for the stock as it believes the worst is over for the sector. According to the brokerage, synergy gains from ACC-Ambuja-Lafarge integration would be an upside.
Jul 20, 2015 at 10:56 | Source:
The brokerage believes the stock is pricing in a 10 percent compound annual rate of decline for JLRs China volume over FY15-17 and margins there contracting to 390 basis points below those in other regions, as well as zero value for the India business.
Jul 17, 2015 at 10:34 | Source:
"Suns strong positioning in key business verticals and synergy benefits from the Ranbaxy turnaround makes it a high conviction buy with an upside of 24 percent," CLSA reasoned.
Jul 17, 2015 at 10:00 | Source:
Sun Pharma gained more than 1 percent as brokerage CLSA raised target price on the stock to Rs 1,160, citing potential of Ranbaxy's Mohali plant. Lupin, too, rose over 1 percent on getting approval from US Food and Drug Administration for diabetes drug PrandiMet.
Messages on Clsa »


Gold Member


Ashok Leyland  

i told you guys that this is a trap to fetch 666cr through qip..all retail investor trap....clsa has given a buy target ...lollzzzzzzzzz

2.15 PM Jul 8th 2014


Platinum Member


Tata Steel  

Tata steel even rally without budget, 3 Points, Increase in Book Value, Underperformer rating by CLSA and only last and only 1 political Point, If Modi , declare tomorrow, steel will be manufactured in India.

12.37 PM Jul 8th 2014


Silver Member


Suzlon Energy  

Absolutely. I too faced the problem when i started investing heavily in 2007. Economy was overheated. e.g. invested in RPL @ 222 on CLSA`s recommendation that it will reach 670 . All numbers looked attractive in the recommendation. I thought will clear my loans in 2 years time. Phew then came

10.30 AM Jul 8th 2014


New Member


Sesa Goa  

Guys one thing is for sure it would not go below Rs.285 as this is price where promoters buy back had happened from the open market. so downside is limited it would not slide back to 250 levels and upside is huge remember blue sky sceanrio given by CLSA 500 with a near term target 350

5.57 PM Jul 7th 2014


New Member

0 Follower

Bharti Airtel  

CLSA gives BUY on Bharti, target 390

5.26 PM Jul 7th 2014

BSE/NSE Announcer

Platinum Member


ILandFS Trans  

IL&FS Transportation Networks Ltd has informed BSE that ITNL International Pte. Ltd, a wholly owned subsidiary of the Company, incorporated in Singapore, has mandated Barclays Bank PLC and CLSA Limited to act as Joint Lead Managers for a Reg S RMB denominated bond offering.

1.27 PM Jul 7th 2014


Platinum Member


Tata Steel  

Buy fast,Co. is doing well, CLSA gave underperformer ratings to tata steel.

10.02 AM Jul 7th 2014


Platinum Member


Tata Steel  

read this news, CLSA on #Tata-Steel-Ltd : Upgrades to Underperform from Sell . Raises target to Rs 550 from Rs 355. See improved margins on resilience of global steel prices. (ETNow) #market-view

2.46 PM Jul 4th 2014


New Member


SKS Microfin  

Sks microfinance is a buy at any level,investors strong buy recently credit rating has been upgraded and rating agency ICRA sees good growth and profit improvement of microfinance industries and many fund managers like morgan Stanley asia,clsa,west fund Mauritius has hike stake in sks microfinance

12.36 PM Jul 4th 2014


Silver Member


Jaiprakash Asso  

qip bought by standard charted and clsa.may see huge upside anytime.Aban offshore recent QIP was marvellous.let see JPA,It has to reach 81 buy any means.

6.17 PM Jul 3rd 2014

News across the web »
Explore Moneycontrol

Copyright © Ltd. All rights reserved. Reproduction of news articles, photos, videos or any other content in whole or in part in any form or medium without express written permission of is prohibited.